140 related articles for article (PubMed ID: 6645495)
1. Binding of progestagens to receptor proteins in MCF-7 cells.
Bergink EW; van Meel F; Turpijn EW; van der Vies J
J Steroid Biochem; 1983 Nov; 19(5):1563-70. PubMed ID: 6645495
[TBL] [Abstract][Full Text] [Related]
2. Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives.
Kloosterboer HJ; Vonk-Noordegraaf CA; Turpijn EW
Contraception; 1988 Sep; 38(3):325-32. PubMed ID: 3139361
[TBL] [Abstract][Full Text] [Related]
3. Binding of a contraceptive progestogen ORG 2969 and its metabolites to receptor proteins and human sex hormone binding globulin.
Bergink EW; Hamburger AD; de Jager E; van der Vies J
J Steroid Biochem; 1981 Feb; 14(2):175-83. PubMed ID: 6451769
[TBL] [Abstract][Full Text] [Related]
4. Receptor binding of allylestrenol, a progestagen of the 19-nortestosterone series without androgenic properties.
Bergink EW; Loonen PB; Kloosterboer HJ
J Steroid Biochem; 1985 Aug; 23(2):165-8. PubMed ID: 3928974
[TBL] [Abstract][Full Text] [Related]
5. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines.
Schoonen WG; Joosten JW; Kloosterboer HJ
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):423-37. PubMed ID: 8541240
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor of the human myometrium.
Illingworth DV; Wood GP; Flickinger GL; Mikhail G
J Clin Endocrinol Metab; 1975 Jun; 40(6):1001-8. PubMed ID: 237014
[TBL] [Abstract][Full Text] [Related]
7. MCF-7; a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors.
Horwitz KB; Costlow ME; McGuire WL
Steroids; 1975 Dec; 26(6):785-95. PubMed ID: 175527
[TBL] [Abstract][Full Text] [Related]
8. Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids.
Veldscholte J; Voorhorst-Ogink MM; Bolt-de Vries J; van Rooij HC; Trapman J; Mulder E
Biochim Biophys Acta; 1990 Apr; 1052(1):187-94. PubMed ID: 2322591
[TBL] [Abstract][Full Text] [Related]
9. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
[TBL] [Abstract][Full Text] [Related]
10. Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins.
Phillips A; Demarest K; Hahn DW; Wong F; McGuire JL
Contraception; 1990 Apr; 41(4):399-410. PubMed ID: 2335104
[TBL] [Abstract][Full Text] [Related]
11. Influence of the substitution of 11-methylene, delta(15), and/or 18-methyl groups in norethisterone on receptor binding, transactivation assays and biological activities in animals.
Deckers GH; Schoonen WG; Kloosterboer HJ
J Steroid Biochem Mol Biol; 2000 Oct; 74(3):83-92. PubMed ID: 11086227
[TBL] [Abstract][Full Text] [Related]
12. Antiprogestin ZK-98.299 and progesterone display differential binding characteristics in the human myometrial cytosol.
D'souza A; Hinduja IN; Puri CP
Biochim Biophys Acta; 1992 Dec; 1175(1):73-80. PubMed ID: 1482698
[TBL] [Abstract][Full Text] [Related]
13. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines.
Schoonen WG; Joosten JW; Kloosterboer HJ
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):439-44. PubMed ID: 8541241
[TBL] [Abstract][Full Text] [Related]
14. Gestodene: a novel synthetic progestin--characterization of binding to receptor and serum proteins.
Pollow K; Juchem M; Grill HJ; Elger W; Beier S; Henderson D; Schmidt-Gollwitzer K; Manz B
Contraception; 1989 Sep; 40(3):325-41. PubMed ID: 2548807
[TBL] [Abstract][Full Text] [Related]
15. Androgenic action of progestins and possible synandrogenic properties of antiandrogens used in oral contraceptives.
Spona J
Gynecol Obstet Invest; 1984; 17(2):66-72. PubMed ID: 6706245
[TBL] [Abstract][Full Text] [Related]
16. Estradiol-17 beta-, progesterone and 5 alpha-dihydrotestosterone receptors of uterine myometrium and myoma in the human subject.
Tamaya T; Motoyama T; Ohono Y; Ide N; Tsurusaki T; Okada H
J Steroid Biochem; 1979 Jun; 10(6):615-22. PubMed ID: 470384
[No Abstract] [Full Text] [Related]
17. Progesterone-binding proteins: in vitro binding and biological activity of different steroidal ligands.
Kontula K; Jänne O; Vihko R; de Jager E; de Visser J; Zeelen F
Acta Endocrinol (Copenh); 1975 Mar; 78(3):574-92. PubMed ID: 164094
[TBL] [Abstract][Full Text] [Related]
18. The interaction of human endometrial and myometrial steroid receptors with danazol.
Jenkin G; Cookson CI; Thorburn GD
Clin Endocrinol (Oxf); 1983 Sep; 19(3):377-88. PubMed ID: 6627694
[TBL] [Abstract][Full Text] [Related]
19. Induction of progesterone receptor with 17 beta-estradiol in human ovarian cancer.
Hamilton TC; Behrens BC; Louie KG; Ozols RF
J Clin Endocrinol Metab; 1984 Sep; 59(3):561-3. PubMed ID: 6746867
[TBL] [Abstract][Full Text] [Related]
20. Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue.
Poortman J; Prenen JA; Schwarz F; Thijssen JH
J Clin Endocrinol Metab; 1975 Mar; 40(3):373-9. PubMed ID: 163841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
